Johny Marice
- Mental Health & Wellness
- May 12, 2026
- 10 views
Arginine Shows Promise in Reducing Alzheimer’s Protein Buildup, Offering Hope for Affordable Treatment
Alzheimer’s disease (AD), a relentless and progressive neurodegenerative disorder, continues to cast a long shadow over global public health, representing the most common cause of dementia worldwide. Despite decades of…
- Mental Health & Wellness
- May 7, 2026
- 8 views
New Hope Emerges in Alzheimer’s Fight: Targeting PTP1B Protein Shows Promise for Memory Improvement
Alzheimer’s disease is a relentless adversary, often quantified by staggering statistics: millions affected worldwide, a rapid increase in diagnosis, and projected economic costs soaring into the trillions. Yet, behind these…
- Mental Health & Wellness
- May 4, 2026
- 12 views
The Promise and Peril of Anti-Amyloid Drugs for Alzheimer’s Disease: A Landmark Review Casts Doubt on Clinical Efficacy and Highlights Safety Concerns
A comprehensive and influential Cochrane review has delivered a significant blow to the long-held therapeutic strategy targeting amyloid beta proteins in the brain for Alzheimer’s disease, concluding that these drugs…
- Mental Health & Wellness
- April 30, 2026
- 14 views
A Novel Protein Target, PTP1B, Shows Promise in Combating Alzheimer’s Disease by Enhancing Brain’s Immune Cell Function and Clearing Amyloid Plaques
Alzheimer’s disease is often described in numbers, with millions of people affected, cases rising quickly, and costs reaching into the trillions. For families, however, the experience is deeply personal. "It’s…
- Mental Health & Wellness
- April 20, 2026
- 14 views
Wake-Promoting Drug Shows Promise in Combating Fatigue for Early Morning Shift Workers
Far more people work very early morning shifts than overnight schedules, yet many struggle with severe fatigue linked to shift work disorder. This condition can interfere with concentration, job performance,…
- Mental Health & Wellness
- April 9, 2026
- 23 views
Wake-Promoting Drug Shows Promise for Early Morning Shift Workers Battling Fatigue
A groundbreaking clinical trial has illuminated a potential new avenue for addressing the pervasive issue of shift work disorder, particularly among the often-overlooked population of early morning shift workers. Researchers…
Kang Muslim
- Human Behavior & Social Studies
- April 6, 2026
- 18 views
Vagus nerve stimulation shows promise as a way to counter Alzheimers disease and age-related memory loss
While Alzheimer’s disease is frequently categorized as a late-life affliction, contemporary neurological research indicates that the foundational shifts in the brain begin decades before the onset of clinical symptoms. Emerging…
- Mental Health & Wellness
- April 1, 2026
- 19 views
Wake-Promoting Drug Solriamfetol Shows Promise for Early Morning Shift Workers Battling Fatigue
Far more people work very early morning shifts than overnight schedules, yet many struggle with severe fatigue linked to shift work disorder. This condition can interfere with concentration, job performance,…
- Mental Health & Wellness
- March 31, 2026
- 19 views
Revolutionary Cellular Immunotherapy Shows Promise for Alzheimer’s Disease with a Single Injection
The landscape of Alzheimer’s disease treatment is on the cusp of a significant transformation, moving beyond therapies that merely slow the progression of this devastating neurodegenerative condition. While recent advancements…
- Mental Health & Wellness
- March 31, 2026
- 17 views
GLP-1 Medications Show Significant Promise in Improving Mental Health Outcomes, New Large-Scale Study Reveals
New research has unveiled a compelling link between GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and obesity, and significant improvements in mental health. A comprehensive study conducted by…
